ZX, T., L, P., L, B., & S, V. (2026). Dapsone use in dermatology: Indication, efficacy and tolerability experience of a UK tertiary dermatology department. Clinical and experimental dermatology, 51(2), 282. https://doi.org/10.1093/ced/llaf464
Chicago Style (17th ed.) CitationZX, Tan, Passby L, Button L, and Velangi S. "Dapsone Use in Dermatology: Indication, Efficacy and Tolerability Experience of a UK Tertiary Dermatology Department." Clinical and Experimental Dermatology 51, no. 2 (2026): 282. https://doi.org/10.1093/ced/llaf464.
MLA (9th ed.) CitationZX, Tan, et al. "Dapsone Use in Dermatology: Indication, Efficacy and Tolerability Experience of a UK Tertiary Dermatology Department." Clinical and Experimental Dermatology, vol. 51, no. 2, 2026, p. 282, https://doi.org/10.1093/ced/llaf464.